DATAHOW AG

Their core work

DATAHOW AG is a Zurich-based technology SME specializing in data analytics and smart sensor systems for biopharmaceutical manufacturing. Their core work centers on Raman-based spectroscopic sensors that enable real-time process monitoring and quality control during drug substance production. They bring expertise in process control engineering and continuous manufacturing — two areas under active regulatory pressure in the pharma industry — making them a specialist provider at the intersection of data science and bioprocessing. Their participation in both a commercial sensor development project and a pan-European PhD training network signals dual engagement in technology commercialization and applied research.

What they specialise in

How they've shifted over time

Both of DATAHOW's H2020 projects launched in 2019, so a meaningful early-vs-late keyword shift cannot be constructed from the available data — all keyword signal sits in the early period via CODOBIO, while SpectraHow carries no indexed keywords. Their 2019 profile combines smart sensing (SpectraHow) with bioprocess engineering and regulatory knowledge (CODOBIO), suggesting a company bridging instrumentation hardware and process science from the outset. With CODOBIO running through 2023, their trajectory points toward deeper integration into the continuous biomanufacturing space, where real-time sensing and process control are converging under the PAT framework.

DATAHOW is positioning at the convergence of real-time process analytics and continuous biopharmaceutical manufacturing — a space with growing regulatory endorsement (FDA, EMA) and significant industry investment in the 2020s.

How they like to work

DATAHOW operates in both roles: they led a small, company-focused SME Instrument feasibility study (SpectraHow) and joined a large MSCA Innovative Training Network (CODOBIO) as an industry partner, contributing real-world manufacturing context to PhD researchers. Their 19 consortium partners across 11 countries, shaped largely by the MSCA network structure, suggests a broad but academically oriented European network rather than a tight industrial supply chain. A future collaborator can expect a technically capable SME comfortable working alongside universities and research institutes on applied problems.

DATAHOW has interacted with 19 unique consortium partners spanning 11 countries, a network predominantly shaped by the multi-partner CODOBIO MSCA training network. Their geographic footprint is pan-European with a Swiss anchor, though Switzerland sits outside the EU funding perimeter.

What sets them apart

DATAHOW is one of very few Swiss SMEs combining proprietary smart Raman sensor hardware with deep process control expertise specifically for biopharmaceutical applications. Unlike pure software analytics companies, they work at the physical measurement layer — which is where data quality in bioprocesses is actually won or lost. Their dual EU project history shows they are taken seriously both as a commercial innovator (SME Instrument grant as coordinator) and as an industry knowledge contributor in academic research consortia.

Highlights from their portfolio

• SpectraHow
  DATAHOW coordinated this SME Instrument Phase 1 project — a direct commercialization push for their smart Raman sensor technology — demonstrating initiative beyond being a passive consortium member.
• CODOBIO
  A long-duration (2019–2023) MSCA Innovative Training Network on continuous downstream bioprocessing, confirming DATAHOW's standing as a credible industry partner within European academic consortia.